Baugh & Associates, LLC
- SEC CIK
- 0001730818
- Latest filing
- Jul 10, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Baugh & Associates, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 50,134
- Value
- $4.55M
- % of portfolio
- 2.0%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 50,134 | $4.55M | 2.0% | −8,162−14.0% | Reduced | Holders |
| Q1 2026 | 58,296 | $5.99M | 2.6% | +7,073+13.8% | Added | Holders |
| Q4 2025 | 51,223 | $5.75M | 2.8% | −1,734−3.3% | Reduced | Holders |
| Q3 2025 | 52,957 | $6.42M | 3.2% | −865−1.6% | Reduced | Holders |
| Q2 2025 | 53,822 | $6.68M | 3.5% | −2,903−5.1% | Reduced | Holders |
| Q1 2025 | 56,725 | $7.15M | 3.6% | −180−0.3% | Reduced | Holders |
| Q4 2024 | 56,905 | $6.16M | 3.2% | −190.0% | Reduced | Holders |
| Q3 2024 | 56,924 | $6.22M | 3.2% | +4,737+9.1% | Added | Holders |
| Q2 2024 | 52,187 | $5.67M | 2.9% | −2,447−4.5% | Reduced | Holders |
| Q1 2024 | 54,634 | $6.21M | 3.3% | −45−0.1% | Reduced | Holders |
| Q4 2023 | 54,679 | $6.02M | 3.5% | −662−1.2% | Reduced | Holders |
| Q3 2023 | 55,341 | $5.36M | 3.4% | −66−0.1% | Reduced | Holders |
| Q2 2023 | 55,407 | $6.04M | 3.6% | +1,124+2.1% | Added | Holders |
| Q1 2023 | 54,283 | $5.61M | 3.6% | −1,295−2.3% | Reduced | Holders |
| Q4 2022 | 55,578 | $6.10M | 4.0% | +537+1.0% | Added | Holders |
| Q3 2022 | 55,041 | $5.33M | 3.8% | −150.0% | Reduced | Holders |
| Q2 2022 | 55,056 | $5.98M | 4.0% | −50−0.1% | Reduced | Holders |
| Q1 2022 | 55,106 | $6.52M | 3.8% | −200−0.4% | Reduced | Holders |
| Q4 2021 | 55,306 | $7.78M | 4.3% | −57−0.1% | Reduced | Holders |
| Q3 2021 | 55,363 | $6.54M | 4.0% | −210.0% | Reduced | Holders |
| Q2 2021 | 55,384 | $6.42M | 4.0% | +2,982+5.7% | Added | Holders |
| Q1 2021 | 52,402 | $6.28M | 4.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.